Using nicotine replacement therapy for smoking reduction in pregnancy: a qualitative study of pregnant women in the UK who smoke.

Autor: Thomson R; Lifespan and Population Health, University of Nottingham School of Medicine, Nottingham, UK Ross.Thomson1@nottingham.ac.uk., Phillips L; Lifespan and Population Health, University of Nottingham School of Medicine, Nottingham, UK., Orton S; Lifespan and Population Health, University of Nottingham School of Medicine, Nottingham, UK., Naughton F; School of Health Sciences, University of East Anglia Faculty of Medicine and Health Sciences, Norwich, UK., Coleman T; Lifespan and Population Health, University of Nottingham School of Medicine, Nottingham, UK.
Jazyk: angličtina
Zdroj: BMJ open [BMJ Open] 2024 Aug 30; Vol. 14 (8), pp. e085945. Date of Electronic Publication: 2024 Aug 30.
DOI: 10.1136/bmjopen-2024-085945
Abstrakt: Objectives: To explore the acceptability and perceived motivations and barriers of using nicotine replacement therapy (NRT) to reduce the number of daily cigarettes smoked in pregnancy, rather than for stopping completely.
Design: Telephone, semi-structured interviews, audio-recorded and transcribed verbatim. Transcripts were analysed using an inductive thematic analysis.
Participants: Eighteen pregnant women in the UK, who were smoking or had recently stopped smoking, were recruited.
Results: Half of interviewees reported having used NRT to reduce smoking during their current pregnancy, and there was overwhelming support for the UK National Health Service to recognise this as a potentially useful way to use these products. The cost and stigma associated with purchasing NRT products when pregnant were seen as barriers to using NRT in this way. The early offer of NRT for reduction along with a tailored, structured approach to support was seen as important.
Conclusions: Using NRT to help women, who are unable to stop smoking, to reduce their smoking may be acceptable to pregnant women. This study found women were already using NRT alongside ad hoc strategies to reduce their smoking. Further research evaluating structured smoking reduction support, alongside concurrent NRT use is needed.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
Databáze: MEDLINE